PHILADELPHIA — A generic pharmaceutical company announced that its CFO has resigned.
Lannett said that Keith Ruck has exited the company to pursue other interests. The company expects to name a successor soon.
“During his tenure, Keith improved the performance of our accounting and financial reporting team,” Lannett president and CEO Arthur Bedrosian said. “In addition, he was instrumental in upgrading our internal controls and business processes. I would like to thank Keith for his hard work and wish him well in his future endeavors.”